Skip To The Main Content

FDA Issues Regulatory Update for Health Professionals

The United States Food and Drug Administration (FDA) has issued an update on its regulatory activities aimed at health care professionals.  The update highlights efforts to develop generic versions of opioid drugs formulated to deter abuse, policies to facilitate development of innovative regenerative medicine products, and the FDA Sentinel program for safety of drugs, biologics, and devices.  To read the FDA regulatory update for health care professionals, use the link below.